Product NDC: | 53104-0211 |
Proprietary Name: | Epirubicin Hydrochloride |
Non Proprietary Name: | Epirubicin Hydrochloride |
Active Ingredient(s): | 2 mg/mL & nbsp; Epirubicin Hydrochloride |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 53104-0211 |
Labeler Name: | Cipla Limited |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA065361 |
Marketing Category: | ANDA |
Start Marketing Date: | 20071022 |
Package NDC: | 53104-0211-6 |
Package Description: | 1 VIAL in 1 CARTON (53104-0211-6) > 25 mL in 1 VIAL |
NDC Code | 53104-0211-6 |
Proprietary Name | Epirubicin Hydrochloride |
Package Description | 1 VIAL in 1 CARTON (53104-0211-6) > 25 mL in 1 VIAL |
Product NDC | 53104-0211 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Epirubicin Hydrochloride |
Dosage Form Name | INJECTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20071022 |
Marketing Category Name | ANDA |
Labeler Name | Cipla Limited |
Substance Name | EPIRUBICIN HYDROCHLORIDE |
Strength Number | 2 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Anthracycline Topoisomerase Inhibitor [EPC],Anthracyclines [Chemical/Ingredient],Topoisomerase Inhibitors [MoA] |